“…Microglia are resident macrophages of the central nervous system (CNS) and are increasingly implicated in brain pathologies such as Alzheimer’s disease (AD), Parkinson’s disease, stroke, brain trauma, schizophrenia, autism, retinal and spinal pathology, as well as brain ageing ( Colonna and Butovsky, 2017 ; Qin et al, 2019 ; Greenhalgh et al, 2020 ; Kwon and Koh, 2020 ; Blaylock and Faria, 2021 ). These dynamic cells carry out disease-modifying functions, including: phagocytosis, degradation, and compaction of amyloid plaques ( Fu et al, 2012 ; Condello et al, 2015 ; Yuan et al, 2016 ; Feng et al, 2020 ; Huang et al, 2021 ; Lemke and Huang, 2022 ); regulation of inflammatory states ( Heneka et al, 2013 ); phagocytosis of synapses ( Stevens et al, 2007 ; Schafer et al, 2012 ; Hong et al, 2016 ); phagocytosis of dead cells and debris ( Sierra et al, 2010 ; Anderson et al, 2022 ); phagocytosis of stressed neurons ( Fricker et al, 2012a , b ); and recruiting peripheral immune cells to the brain ( Zhang et al, 2022 ). Thus, it is important to better understand the intracellular signalling pathways controlling these contrasting functions of microglia.…”